Carbapenems and Monobactams: Imipenem, Meropenem, and Aztreonam

This publication has 172 references indexed in Scilit:

• Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?
  Diagnostic Microbiology and Infectious Disease, 1994
• Antimicrobial activity of cefepime tested against bush group I β-lactamase-producing strains resistant to ceftazidime a multilaboratory national and international clinical isolate study
  Diagnostic Microbiology and Infectious Disease, 1994
• A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States
  Diagnostic Microbiology and Infectious Disease, 1994
• Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery
  European Journal of Clinical Microbiology & Infectious Diseases, 1993
• Effect of meropenem on the intestinal microflora
  European Journal of Clinical Microbiology & Infectious Diseases, 1991
• Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections
  Tubercle, 1990
• In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338
  European Journal of Clinical Microbiology & Infectious Diseases, 1989
• Nocardial cerebral abscess cured with imipenem/amikacin and enucleation
  Neurosurgical Review, 1989
• A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam
  European Journal of Clinical Microbiology & Infectious Diseases, 1984
• Impact of imipenem/cilastatin therapy on faecal flora
  European Journal of Clinical Microbiology & Infectious Diseases, 1984